Insimbi Industrial Holdings Ltd
JSE:ISB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Insimbi Industrial Holdings Ltd
JSE:ISB
|
ZA |
|
S
|
Sogn Sparebank
OSE:SOGN
|
NO |
|
Corum Group Ltd
ASX:COO
|
AU |
|
S
|
Shandong Weigao Blood Purification Products Co Ltd
SSE:603014
|
CN |
|
C
|
Chykingyoung Investment Development Holdings Inc
OTC:CHYI
|
CA |
|
Blusky AI Inc
OTC:BSAI
|
US |
|
Taitron Components Inc
NASDAQ:TAIT
|
US |
|
S
|
Sinco Pharmaceuticals Holdings Ltd
HKEX:6833
|
CN |
|
I
|
Incheon City Gas Co Ltd
KRX:034590
|
KR |
|
B
|
Bytetravel SA
MAD:SCBYT
|
ES |
Balance Sheet
Balance Sheet Decomposition
Insimbi Industrial Holdings Ltd
Insimbi Industrial Holdings Ltd
Balance Sheet
Insimbi Industrial Holdings Ltd
| Feb-2006 | Feb-2007 | Feb-2008 | Feb-2009 | Feb-2010 | Feb-2011 | Feb-2012 | Feb-2013 | Feb-2014 | Feb-2015 | Feb-2016 | Feb-2017 | Feb-2018 | Feb-2019 | Feb-2020 | Feb-2021 | Feb-2022 | Feb-2023 | Feb-2024 | Feb-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||
| Cash & Cash Equivalents |
12
|
38
|
8
|
42
|
27
|
38
|
37
|
34
|
49
|
28
|
10
|
30
|
32
|
34
|
93
|
68
|
57
|
97
|
75
|
32
|
|
| Cash |
12
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
93
|
68
|
57
|
97
|
75
|
32
|
|
| Cash Equivalents |
0
|
38
|
8
|
42
|
27
|
38
|
37
|
34
|
49
|
28
|
10
|
30
|
32
|
34
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
3
|
0
|
1
|
1
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
56
|
130
|
103
|
101
|
98
|
107
|
118
|
94
|
120
|
133
|
148
|
279
|
299
|
415
|
485
|
720
|
621
|
603
|
631
|
569
|
|
| Accounts Receivables |
55
|
130
|
103
|
99
|
98
|
103
|
113
|
91
|
117
|
132
|
148
|
276
|
294
|
410
|
441
|
657
|
532
|
530
|
555
|
496
|
|
| Other Receivables |
1
|
0
|
0
|
2
|
0
|
4
|
5
|
3
|
3
|
0
|
0
|
3
|
5
|
5
|
44
|
63
|
89
|
72
|
76
|
73
|
|
| Inventory |
42
|
64
|
75
|
73
|
55
|
63
|
73
|
66
|
83
|
86
|
88
|
153
|
148
|
168
|
197
|
198
|
328
|
305
|
335
|
330
|
|
| Other Current Assets |
0
|
1
|
2
|
2
|
4
|
6
|
5
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
11
|
4
|
5
|
19
|
18
|
28
|
|
| Total Current Assets |
109
|
233
|
190
|
217
|
184
|
214
|
232
|
195
|
253
|
248
|
247
|
461
|
479
|
617
|
786
|
991
|
1 012
|
1 023
|
1 059
|
959
|
|
| PP&E Net |
9
|
9
|
11
|
19
|
23
|
34
|
35
|
79
|
78
|
78
|
117
|
239
|
271
|
363
|
459
|
436
|
392
|
363
|
347
|
298
|
|
| PP&E Gross |
9
|
9
|
11
|
19
|
23
|
34
|
35
|
79
|
78
|
0
|
0
|
0
|
0
|
0
|
459
|
436
|
392
|
363
|
347
|
298
|
|
| Accumulated Depreciation |
7
|
9
|
10
|
13
|
16
|
21
|
25
|
24
|
31
|
0
|
0
|
0
|
0
|
0
|
172
|
214
|
226
|
179
|
181
|
155
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
4
|
5
|
7
|
8
|
11
|
12
|
12
|
13
|
11
|
8
|
7
|
7
|
14
|
12
|
|
| Goodwill |
30
|
30
|
30
|
40
|
40
|
38
|
36
|
36
|
36
|
36
|
45
|
108
|
108
|
165
|
170
|
170
|
170
|
170
|
170
|
93
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
3
|
3
|
3
|
2
|
2
|
1
|
|
| Long-Term Investments |
2
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
2
|
2
|
3
|
6
|
4
|
|
| Other Long-Term Assets |
1
|
1
|
1
|
3
|
4
|
4
|
4
|
7
|
12
|
12
|
9
|
8
|
3
|
4
|
7
|
14
|
11
|
25
|
5
|
6
|
|
| Other Assets |
30
|
30
|
30
|
40
|
40
|
38
|
36
|
36
|
36
|
36
|
45
|
108
|
108
|
165
|
170
|
170
|
170
|
170
|
170
|
93
|
|
| Total Assets |
151
N/A
|
276
+82%
|
232
-16%
|
279
+20%
|
252
-10%
|
290
+15%
|
311
+7%
|
321
+3%
|
386
+20%
|
383
-1%
|
427
+12%
|
828
+94%
|
873
+5%
|
1 167
+34%
|
1 438
+23%
|
1 624
+13%
|
1 597
-2%
|
1 593
0%
|
1 604
+1%
|
1 373
-14%
|
|
| Liabilities | |||||||||||||||||||||
| Accounts Payable |
51
|
151
|
99
|
107
|
89
|
105
|
124
|
106
|
164
|
161
|
0
|
162
|
192
|
248
|
194
|
293
|
308
|
248
|
267
|
232
|
|
| Accrued Liabilities |
2
|
3
|
4
|
3
|
9
|
9
|
4
|
6
|
6
|
0
|
0
|
0
|
0
|
0
|
21
|
38
|
56
|
31
|
16
|
15
|
|
| Short-Term Debt |
0
|
14
|
1
|
8
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
95
|
48
|
154
|
330
|
420
|
351
|
355
|
404
|
416
|
|
| Current Portion of Long-Term Debt |
11
|
19
|
26
|
1
|
32
|
59
|
46
|
65
|
57
|
58
|
60
|
11
|
34
|
3
|
1
|
1
|
3
|
2
|
3
|
2
|
|
| Other Current Liabilities |
9
|
13
|
14
|
11
|
6
|
2
|
13
|
7
|
4
|
5
|
0
|
3
|
3
|
1
|
2
|
12
|
11
|
14
|
24
|
1
|
|
| Total Current Liabilities |
73
|
200
|
143
|
130
|
137
|
175
|
187
|
184
|
234
|
224
|
213
|
271
|
277
|
405
|
547
|
764
|
729
|
650
|
714
|
666
|
|
| Long-Term Debt |
30
|
10
|
85
|
57
|
42
|
35
|
0
|
20
|
16
|
14
|
51
|
213
|
168
|
275
|
383
|
303
|
214
|
186
|
148
|
124
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
11
|
16
|
14
|
14
|
26
|
29
|
36
|
38
|
44
|
37
|
55
|
34
|
27
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
36
|
0
|
0
|
0
|
0
|
0
|
0
|
6
|
1
|
1
|
1
|
0
|
0
|
0
|
|
| Total Liabilities |
103
N/A
|
211
+104%
|
228
+8%
|
187
-18%
|
179
-5%
|
210
+18%
|
223
+6%
|
215
-3%
|
265
+23%
|
250
-6%
|
275
+10%
|
511
+85%
|
474
-7%
|
721
+52%
|
969
+34%
|
1 112
+15%
|
981
-12%
|
891
-9%
|
895
+1%
|
817
-9%
|
|
| Equity | |||||||||||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
44
|
44
|
44
|
44
|
44
|
197
|
197
|
198
|
209
|
231
|
230
|
206
|
198
|
153
|
|
| Retained Earnings |
48
|
65
|
4
|
47
|
29
|
35
|
46
|
46
|
86
|
103
|
122
|
139
|
222
|
248
|
260
|
304
|
408
|
506
|
521
|
369
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
44
|
44
|
44
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
20
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
42
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
3
|
5
|
9
|
15
|
0
|
18
|
19
|
0
|
0
|
22
|
22
|
10
|
11
|
7
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
48
N/A
|
65
+35%
|
4
-94%
|
92
+2 141%
|
73
-21%
|
80
+9%
|
88
+10%
|
106
+21%
|
121
+14%
|
133
+10%
|
152
+15%
|
318
+109%
|
399
+26%
|
446
+12%
|
469
+5%
|
512
+9%
|
616
+20%
|
702
+14%
|
708
+1%
|
556
-21%
|
|
| Total Liabilities & Equity |
151
N/A
|
276
+82%
|
232
-16%
|
279
+20%
|
252
-10%
|
290
+15%
|
311
+7%
|
321
+3%
|
386
+20%
|
383
-1%
|
427
+12%
|
828
+94%
|
873
+5%
|
1 167
+34%
|
1 438
+23%
|
1 624
+13%
|
1 597
-2%
|
1 593
0%
|
1 604
+1%
|
1 373
-14%
|
|
| Shares Outstanding | |||||||||||||||||||||
| Common Shares Outstanding |
260
|
260
|
260
|
260
|
260
|
260
|
257
|
253
|
247
|
237
|
236
|
387
|
386
|
404
|
414
|
413
|
395
|
372
|
364
|
321
|
|